Philips launches bi-level ventilator for management of chronic respiratory insufficiency
BiPAP 40 launched to coincide with World COPD Day
Philips Respironics has launched its new bi-level ventilator, the BiPAP A40, for the management of chronic respiratory insufficiency.
,Launched on World COPD Day 2012 and being showcased this week at Medica 2012, the device improves the management of chronic respiratory diseases from initial titration to hospital discharge and from home therapy to long-term follow-up.
“Philips is proud to be able to provide access to new and innovative solutions that improve quality of care for respiratory patients, both in hospital and at home,” said Mats Dahlquist, general manager of international business at Philips Home Healthcare Solutions.
“One of the key benefits of the BiPAP A40 is an innovative ventilation mode called AVAPS-AE, which helps guide clinicians during the initial titration of therapy while maintaining comfort and improving efficacy for the patient. This new ventilation mode automatically maintains airway patency while delivering the correct level of ventilation each user requires, whatever their body position or sleep stage. AVAPS-AE mode also helps guide clinicians during the initial titration of therapy, while providing long-term comfort and assuring therapy compliance.”
In addition to the introduction of AVAPS-AE, the BiPAP A40 features a unique battery module design that provides users with an enhanced level of support when travelling or in the case of a power shortage. Furthermore, the design incorporates an intuitive user interface and data management tools that allow clinicians to remotely access and review data about a user’s therapy, adjusting it as necessary. This can help to reduce therapy dropout and the associated risk of hospital re-admission.